Cinpanemab (Biosimilar Reference Antibody) (SNCA)
Cinpanemab (Biosimilar Reference Antibody) (SNCA)
Cinpanemab (Biosimilar Reference Antibody) (SNCA)-RA0698-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.
ELISA plate pre-coated Antigen protein, can bind Cinpanemab (Biosimilar Reference Antibody) (SNCA)-RA0695 in a linear range of 3.91-125 ng/mL.
Cinpanemab (Biosimilar Reference Antibody) (SNCA)

Catalog: 

RA0695

Target

SNCA

Isotype

IgG1 - lambda

Applications

ELISA;FC;Functional Assays;IF

Reactivities

Human

Size ($):

100 μg-50;1 mg-210;5 mg-500;10 mg-800;25 mg-1750;50 mg-3000;100 mg-4600

Data Sheet

Material Safety Data Sheet

Certificate of Analysis

Product Description

Cinpanemab (also known as BIIB054) is an investigational human monoclonal antibody that was developed for the potential treatment of Parkinson's disease. It specifically targets a pathological form of a protein that is central to the disease's progression. The drug was designed based on the alpha-synuclein hypothesis, which posits that the aggregation and spread of misfolded alpha-synuclein in the brain drives neurodegeneration. Cinpanemab was evaluated in late-stage clinical trials (Phase II) with the goal of slowing disease progression, but its development was ultimately discontinued after the trial failed to meet its primary efficacy endpoints.

Synonyms

BIIB-054

CAS

2094516-02-4

Isotype

IgG1 - lambda

Host

Humanized

Target

SNCA

Reactivity

Human

Expression System

CHO

Applications

ELISA, FC, Functional Assays, IF; Recommended dilution: FC, IF:1:200

Purity

>98% by SDS-PAGE

Concentration

Bottled at the concentration indicated on the vial.

Buffer

0.01M PBS, pH 7.4, contains no stabilizers or preservatives.

Endotoxin

<1.0 EU/mg as determined by LAL method

Conjugation

Non-conjugated

Formulation

Liquid or Lyophilized powder Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Storage

store at -20°C or -80°C. Avoid repeated freeze.

Type

Antibody

Purposes

For research use only

References 1

Lang AE, et, al. Trial of Cinpanemab in Early Parkinson's Disease. N Engl J Med. 2022 Aug 4;387(5):408-420.

References 2

Teng JS, et, al. Immunotherapies for Parkinson's Disease: Progression of Clinical Development. CNS Neurol Disord Drug Targets. 2021;20(9):802-813.

References 3

References 4

References 5

Product Citations 1

Product Citations 2

https://pubmed.ncbi.nlm.nih.gov/35921450/
https://pubmed.ncbi.nlm.nih.gov/34042040/
https://www.oursmab.com/News/Parkinson-s-disease-treatment-target-SNCA.html

Target Description

Synonyms

synuclein alpha, PARK1, PARK4, "Parkinson disease (autosomal dominant, Lewy body) 4", "synuclein, alpha (non A4 component of amyloid precursor)"

Biology Area

Neuroscience

Function

alpha-synuclein (α-synuclein), particularly oligomers and protofibrils. Alpha-synuclein is a presynaptic neuronal protein that, in its native state, is soluble and involved in synaptic function. In Parkinson's disease, it misfolds and aggregates into soluble oligomers and insoluble fibrils, which are the main components of Lewy bodies—the pathological hallmark of the disease. These aggregated species are believed to be toxic, contributing to neuronal dysfunction, inflammation, and cell-to-cell transmission of pathology.

Additional Articles 1

Parkinson-s-disease-treatment-target-SNCA

Additional Articles 2

Related Products

Catalog: 

RA0695

Target:

CEACAM-1/CD66a

Isotype:

IgG4 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0695

Target:

CD274/PDL1/B7H1

Isotype:

IgG - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0695

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0695

Target:

IL6R/CD126

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0695

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0695

Target:

IL7R/CD127

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0695

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0695

Target:

IL7R/CD127

Isotype:

IgG4 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0695

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0695

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Contact Us

Send your request

Talk to us 

Get a quotation, discuss your requirement, receive advises from our antibody experts without obligation.